Real-time enrollment status for this higher-risk myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 4:57 AM UTC
| NCT Number | NCT06641414 |
| Recruiting Status | Recruiting |
| Condition | Higher-risk Myelodysplastic Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 490 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Ascentage Pharma Group Inc. |
| Last Updated on CT.gov | October 13, 2026 (Yesterday) |
As of October 14, 2026: Clinical trial NCT06641414 is currently recruiting participants. This phase3 study for higher-risk myelodysplastic syndrome is actively seeking new participants at 40 locations across the United States. The study is sponsored by Ascentage Pharma Group Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06641414 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06641414 was last updated Yesterday (October 13, 2026). HelloStudys verifies this status automatically.